İbrahim Ethem Pınar

16PUBLICATIONS
108CO-AUTHORS
Medical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyCardiovascular medicine and haematology not elsewhere classifiedMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 27, 2026
Infectious Burden and Immortal-Time Bias During AML Induction: A Supportive-Care Cohort Under Posaconazole Prophylaxis.

|Oct 16, 2026
Immunoglobulin A Subtype and Survival After Upfront Autologous Stem Cell Transplantation in Multiple Myeloma: A Real-World Cohort from the Bortezomib Era.

|Aug 27, 2026
Pre-Transplant Endothelial Activation and Stress Index (EASIX) and Albumin-Modified mEASIX (mEASIX_alb) Predict Survival in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation.

|Aug 27, 2026
Beyond the Thrombophilia Panel: Real-World Overuse, Limited Interpretability, and Poor Guideline Concordance in a Hematology Referral Cohort.

|Jan 28, 2026
Macrocytosis as an Early Pharmacodynamic Marker of Imatinib Efficacy in Chronic Myeloid Leukemia.

Fatih Yaman, Ibrahim Ethem Pinar, Sevgi Isik

|Jan 28, 2026
Original Versus Generic Eltrombopag in Patients with Immune Thrombocytopenia: A Prospective Multi-Center Experience on Efficacy and Safety.

Serhat Çelik, Zeynep Tuğba Karabulut, Cem Selim

Pageof 3

Frequent Collaborators

10 joint publications

Fahir Ozkalemkas

6 joint publications

Tuba Ersal

4 joint publications

Serhat Celik

4 joint publications

Volkan Karakus